Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CELSR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HNRNPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBALD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QPCTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERGIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DCAF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EBPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1QTNF3-AMACR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUTA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RDH13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on